In accordance with 5 CFR 1320, the information collection is approved for three years. However, should the agency changes the survey instrument as outlined in the supplementary document "Gluten Addendum," they must submit the final draft for OMB approval prior to conducting the survey. They may submit their request for approval as a "non-substantive" change.
Inventory as of this Action
Requested
Previously Approved
02/28/2013
36 Months From Approved
17,140
0
0
2,015
0
0
0
0
0
Under section 903b of the Federal food Drug and Cosmetic Act (the act),(21 U.S.C.393 (b)(2), FDA is authorized to conduct research relating to foods and to conduct educational and public information programs relating to the safety of the nations food supply. The 'Gluten - Free Labeling of Food Products Experimental study" will collect infomationfrom both consumers who have celiac disease or gluten intolerance and those who do not have either condition. The purpose of the study is to guage perceptions of characteristics related to claims of "gluten free." Further, the results of this study will be used to help FDA define how gluten-free terms can be used on food product labels.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.